News
SIBN
18.59
+0.38%
0.07
Weekly Report: what happened at SIBN last week (0914-0918)?
Weekly Report · 4d ago
Analysts Offer Insights on Healthcare Companies: SI-Bone (SIBN), BioNTech SE (BNTX) and Medtronic (MDT)
TipRanks · 09/15 12:10
At a glance: stocks gapping up premarket
Seeking Alpha · 09/14 11:21
Weekly Report: what happened at SIBN last week (0907-0911)?
Weekly Report · 09/14 09:51
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 09/11 21:06
SI-BONE Announces Voluntary Recall of iFuse TORQ Implants
TipRanks · 09/11 20:33
Weekly Report: what happened at SIBN last week (0831-0904)?
Weekly Report · 09/07 09:47
Weekly Report: what happened at SIBN last week (0824-0828)?
Weekly Report · 08/31 09:52
Si-Bone (SIBN) is a Great Momentum Stock: Should You Buy?
NASDAQ · 08/25 16:00
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 25.25%: Here's is How to Trade
NASDAQ · 08/24 13:55
Weekly Report: what happened at SIBN last week (0817-0821)?
Weekly Report · 08/24 09:52
Top SI-Bone Executives Quietly Cash In On Recent Stock Moves
TipRanks · 08/19 02:03
Weekly Report: what happened at SIBN last week (0810-0814)?
Weekly Report · 08/17 09:53
Weekly Report: what happened at SIBN last week (0803-0807)?
Weekly Report · 08/10 09:50
Si-Bone’s New Real-World Pelvic Fracture Study: What Investors Should Watch
TipRanks · 08/07 16:30
SI‑BONE Earnings Call Highlights Growth And Margin Strength
TipRanks · 08/05 00:48
UBS Maintains Buy on SI-BONE, Raises Price Target to $25
Benzinga · 08/04 19:25
Truist Securities Reiterates Buy on SI-BONE, Raises Price Target to $23
Benzinga · 08/04 16:48
TD Cowen Maintains Buy on SI-BONE, Raises Price Target to $20
Benzinga · 08/04 16:31
SI-Bone (SIBN) Receives a Buy from Piper Sandler
TipRanks · 08/04 13:45
More
Webull provides a variety of real-time SIBN stock news. You can receive the latest news about Si-Bone through multiple platforms. This information may help you make smarter investment decisions.
About SIBN
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.